Rachel Cusatis

assistant professor, social scientist, patient centered outcomes & research, mixed methods, mke lover, berner dog mom

[Society for Immunotherapy of Cancer @sitcancer]

The upcoming #virtual Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies program on Sept. 11, features authorities in cancer immunotherapy. Address toxicities beyond CRS and ICANS. Register now: https://t.co/Boa0Lmc1d6

@MJFzeta @rncusatis @LoriMuffly

[TOPcast @topcastnow]

TOPcast ep130 includes shoutouts to @tjoosten @DETAResearch @UWM @rncusatis @katrinamwehr @YESPLZdotCOFFEE and more! https://t.co/Idrz4jqpk8

[Stem Cell Evidence @evidencestemc]

One of our top ten articles this month: @rncusatis in @AjHematology on Health-related quality of life in reduced intensity HSCT based on donor availability in patients aged 50-75 with advanced #MDS
https://t.co/tELr9X548A
#BMT #StemCellEvidence

[Tanya Joosten @tjoosten]

@DETAResearch @rncusatis @LindseyHarness Read the article and download the infographic on @DETAResearch's new site, https://t.co/8CHyX7m8To.

[Warren Fingrut @warren_fingrut]

3rd Health Services Oral: CAR-T Recipients & Worsening Financial Impact over Time: A Mixed Methods Longitudinal Study

by @rncusatis & coauthors @CIBMTR @MedicalCollege @StanfordBMT_CT

https://t.co/j33VdlfZyw

[BMT CTN @BMTCTN]

Looking forward to hearing various perspectives from #BMTCTN 1102 study Co-Chair @DrCCutler, #BMTCTN Evidence into Practice members Drs. Chandra & Kindwall-Keller &
#BMTCTN QOL Cmte member @rncusatis
Thanks @BeTheMatch for offering this session to highlight the study findings! https://t.co/tO7WYQjJIL

[Stem Cell Evidence @evidencestemc]

One of our current top ten articles: Adding centralized electronic patient-reported outcome (PRO) data collection to an established international clinical outcomes registry. @rncusatis et al in @ASTCT_Journal https://t.co/HGGYvkyxfM
#BMT #StemCellEvidence

[Rachel Cusatis @rncusatis]

@benwedell @Chuckwood_21 Thanks to @LindseyHarness for the amazing soup 🥣🥰

[Rachel Cusatis @rncusatis]

@LoriMuffly @SurbhiSidanaMD @StanfordBMT_CT @irenatanMD Couldn’t agree more! Really grateful for you all and this collaboration!

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

🙏 @SurbhiSidanaMD @adsouza_md et al for addressing important #ASH21 topic: financial toxicity with #TcellRx.

SW colleagues are EXCELLENT at supporting pts leading into CAR-T therapy, but more work needed on other side.

CAR-T outcomes: Achieving MRD-neg 👍, creating GoFundMe 👎

[Surbhi Sidana, MD @SurbhiSidanaMD]

#ASH21

Financial toxicity with CAR-T therapy, excellent presentation by @rncusatis! @LoriMuffly @StanfordBMT_CT

- Increasing FT with time
-Lodging, travel, insurance coverage, need to give up other things are common themes

[Lena Winestone, MD MSHP @drlenawine]

Not surprisingly, patients experience financial toxicity following #CARTcell #CellTherapy as presented by @rncusatis at #ASH21. Their qualitative data highlight the need for additional support for lodging and relocation in order to ensure #accesstocare @LoriMuffly @adsouza_md

[Warren Fingrut @warren_fingrut]

Worsening Financial Toxicity Among Pts Receiving CAR-T: Longitudinal Study
➡️ COST-FACIT scores highest @ baseline: indicates higher financial well-being; large range suggests pts come into CAR-T at different levels of financial tox.
➡️ Financial well-being declined over time

[Surbhi Sidana, MD @SurbhiSidanaMD]

#ASH21 #cartsm Coming up shortly: Our work on financial toxicity in pts undergoing CAR-T therapy.

Joint study at @StanfordBMT_CT and MCW. Will be presented by Dr Cusatis.

[CIBMTR @CIBMTR]

Attending #ASH21? CIBMTR investigators will present >30 abstracts, this weekend. Take a look at today’s abstract presentations below and see the full list on our website! https://t.co/vUWT61oVjL

[BMT CTN @BMTCTN]

If you are attending #ASH21 don't forget to check out #BMTCTN abstract presentations!

[Dr Raul Pacheco-Vega @raulpacheco]

Qualitative methods, mixed methods, quantitative methods.

[Rachel Cusatis @rncusatis]

@ChrisFerraroCNP @BldCancerDoc @ASTCT @ASTCT_Journal @hamiltkyb Would LOVE to hear more!

[Rachel Cusatis @rncusatis]

@ivanmurrietaa @ASTCT @ASTCT_Journal Agree PROs can be gold when used correctly! Are you using FACT PROs for provider use only? Or sharing with patients?

[Rachel Cusatis @rncusatis]

@page_md @vedranr @ASTCT @ASTCT_Journal @dancourielBMT Would love to chat more about this! 😄